These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9748012)

  • 1. Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy. NGF Study Group.
    Apfel SC; Kessler JA; Adornato BT; Litchy WJ; Sanders C; Rask CA
    Neurology; 1998 Sep; 51(3):695-702. PubMed ID: 9748012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy: A randomized controlled trial. rhNGF Clinical Investigator Group.
    Apfel SC; Schwartz S; Adornato BT; Freeman R; Biton V; Rendell M; Vinik A; Giuliani M; Stevens JC; Barbano R; Dyck PJ
    JAMA; 2000 Nov; 284(17):2215-21. PubMed ID: 11056593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral neuropathy in transgenic diabetic mice: restoration of C-fiber function with human recombinant nerve growth factor.
    Elias KA; Cronin MJ; Stewart TA; Carlsen RC
    Diabetes; 1998 Oct; 47(10):1637-42. PubMed ID: 9753304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of ubiquinone in diabetic polyneuropathy: a randomized double-blind placebo-controlled study.
    Hernández-Ojeda J; Cardona-Muñoz EG; Román-Pintos LM; Troyo-Sanromán R; Ortiz-Lazareno PC; Cárdenas-Meza MA; Pascoe-González S; Miranda-Díaz AG
    J Diabetes Complications; 2012; 26(4):352-8. PubMed ID: 22595020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human nerve growth factor and diabetic polyneuropathy.
    Zochodne DW; Said G
    Neurology; 1998 Sep; 51(3):662-3. PubMed ID: 9748004
    [No Abstract]   [Full Text] [Related]  

  • 6. [Nerve growth factor (NGF) in treatment of diabetic polyneuropathy. One hope less?].
    Quasthoff S; Hartung HP
    Nervenarzt; 2001 Jun; 72(6):456-9. PubMed ID: 11433707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aldose reductase inhibitor ranirestat significantly improves nerve conduction velocity in diabetic polyneuropathy: A randomized double-blind placebo-controlled study in Japan.
    Sekiguchi K; Kohara N; Baba M; Komori T; Naito Y; Imai T; Satoh J; Yamaguchi Y; Hamatani T;
    J Diabetes Investig; 2019 Mar; 10(2):466-474. PubMed ID: 29975462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human studies of recombinant human nerve growth factor and diabetic peripheral neuropathy.
    Freeman R
    Eur Neurol; 1999; 41 Suppl 1():20-6. PubMed ID: 10023125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy.
    Riggs JE
    Neurology; 1999 Apr; 52(7):1517-8. PubMed ID: 10227655
    [No Abstract]   [Full Text] [Related]  

  • 10. The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial.
    Ametov AS; Barinov A; Dyck PJ; Hermann R; Kozlova N; Litchy WJ; Low PA; Nehrdich D; Novosadova M; O'Brien PC; Reljanovic M; Samigullin R; Schuette K; Strokov I; Tritschler HJ; Wessel K; Yakhno N; Ziegler D;
    Diabetes Care; 2003 Mar; 26(3):770-6. PubMed ID: 12610036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of aldose reductase inhibitor treatment in diabetic polyneuropathy - a clinical and neurophysiological study.
    Fagius J; Jameson S
    J Neurol Neurosurg Psychiatry; 1981 Nov; 44(11):991-1001. PubMed ID: 6801211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological actions of nerve growth factor in the peripheral nervous system.
    Rask CA
    Eur Neurol; 1999; 41 Suppl 1():14-9. PubMed ID: 10023124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intradermal recombinant human nerve growth factor induces pressure allodynia and lowered heat-pain threshold in humans.
    Dyck PJ; Peroutka S; Rask C; Burton E; Baker MK; Lehman KA; Gillen DA; Hokanson JL; O'Brien PC
    Neurology; 1997 Feb; 48(2):501-5. PubMed ID: 9040746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind placebo-controlled clinical trial of recombinant human brain-derived neurotrophic factor (rhBDNF) in diabetic polyneuropathy.
    Wellmer A; Misra VP; Sharief MK; Kopelman PG; Anand P
    J Peripher Nerv Syst; 2001 Dec; 6(4):204-10. PubMed ID: 11800042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical Citrullus colocynthis (bitter apple) extract oil in painful diabetic neuropathy: A double-blind randomized placebo-controlled clinical trial.
    Heydari M; Homayouni K; Hashempur MH; Shams M
    J Diabetes; 2016 Mar; 8(2):246-52. PubMed ID: 25800045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of diabetic polyneuropathy with the neurotrophic peptide ORG 2766.
    Valk GD; Kappelle AC; Tjon-A-Tsien AM; Bravenboer B; Bakker K; Michels RP; Groenhout CM; Bertelsmann FW
    J Neurol; 1996 Mar; 243(3):257-63. PubMed ID: 8936356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetyl-L-carnitine (levacecarnine) in the treatment of diabetic neuropathy. A long-term, randomised, double-blind, placebo-controlled study.
    De Grandis D; Minardi C
    Drugs R D; 2002; 3(4):223-31. PubMed ID: 12455197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cilostazol: a pilot study on safety and clinical efficacy in neuropathies of diabetes mellitus type 2 (ASCEND).
    Rosales RL; Santos MM; Mercado-Asis LB
    Angiology; 2011 Nov; 62(8):625-35. PubMed ID: 21733952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nerve growth factor for the treatment of diabetic neuropathy: what went wrong, what went right, and what does the future hold?
    Apfel SC
    Int Rev Neurobiol; 2002; 50():393-413. PubMed ID: 12198818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of ranirestat in patients with mild-to-moderate diabetic sensorimotor polyneuropathy.
    Polydefkis M; Arezzo J; Nash M; Bril V; Shaibani A; Gordon RJ; Bradshaw KL; Junor RW;
    J Peripher Nerv Syst; 2015 Dec; 20(4):363-71. PubMed ID: 26313450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.